Details for New Drug Application (NDA): 062654
✉ Email this page to a colleague
NDA 062654 describes ROCEPHIN, which is a drug marketed by Hoffmann La Roche and Roche and is included in five NDAs. Additional details are available on the ROCEPHIN profile page.
The generic ingredient in ROCEPHIN is ceftriaxone sodium; lidocaine. There are twenty-six drug master file entries for this compound. Additional details are available on the ceftriaxone sodium; lidocaine profile page.
The generic ingredient in ROCEPHIN is ceftriaxone sodium; lidocaine. There are twenty-six drug master file entries for this compound. Additional details are available on the ceftriaxone sodium; lidocaine profile page.
Summary for 062654
| Tradename: | ROCEPHIN |
| Applicant: | Hoffmann La Roche |
| Ingredient: | ceftriaxone sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062654
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
| Approval Date: | Apr 30, 1987 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Apr 30, 1987 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Apr 30, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
